ReportWire

Tag: Women's Health

  • Software providers test health care AI bots, but are they accurate?

    Software providers test health care AI bots, but are they accurate?

    [ad_1]

    Software providers test health care AI bots, but are they accurate? – CBS News


    Watch CBS News



    With medical providers facing rising levels of burnout, software designers are testing specialized AI-powered chatbots that they hope provide preventative care advice to patients. However, CBS News Confirmed found that the summaries given from existing AI bots like ChatGPT aren’t always accurate.

    Be the first to know

    Get browser notifications for breaking news, live events, and exclusive reporting.


    [ad_2]

    Source link

  • 5/1: The Daily Report with John Dickerson

    5/1: The Daily Report with John Dickerson

    [ad_1]

    5/1: The Daily Report with John Dickerson – CBS News


    Watch CBS News



    John Dickerson reports on the status of pro-Palestinian protests on college campuses, a strict abortion ban becoming law in Florida, and the impact of another round of student debt relief from the Biden administration.

    Be the first to know

    Get browser notifications for breaking news, live events, and exclusive reporting.


    [ad_2]

    Source link

  • 5/1: CBS Evening News

    5/1: CBS Evening News

    [ad_1]

    5/1: CBS Evening News – CBS News


    Watch CBS News



    Several college protests turn violent; police called in to clear encampments; Bee colony delays Arizona Diamondbacks game

    Be the first to know

    Get browser notifications for breaking news, live events, and exclusive reporting.


    [ad_2]

    Source link

  • 5/1: America Decides

    5/1: America Decides

    [ad_1]

    5/1: America Decides – CBS News


    Watch CBS News



    Florida’s six-week abortion ban takes effect; former first lady Michelle Obama surprises students for college signing day.

    Be the first to know

    Get browser notifications for breaking news, live events, and exclusive reporting.


    [ad_2]

    Source link

  • 4/10: CBS Evening News

    4/10: CBS Evening News

    [ad_1]

    4/10: CBS Evening News – CBS News


    Watch CBS News



    Gulf Coast hit with tornadoes and flooding; Rosie the Riveters honored with Congressional Gold Medal

    Be the first to know

    Get browser notifications for breaking news, live events, and exclusive reporting.


    [ad_2]

    Source link

  • 4/9: CBS Evening News

    4/9: CBS Evening News

    [ad_1]

    4/9: CBS Evening News – CBS News


    Watch CBS News



    Arizona Supreme Court rules abortion ban from 1864 can be enforced; Nonprofit provides free guide dogs for the visually impaired

    Be the first to know

    Get browser notifications for breaking news, live events, and exclusive reporting.


    [ad_2]

    Source link

  • Supreme Court hears arguments in abortion pill case

    Supreme Court hears arguments in abortion pill case

    [ad_1]

    Supreme Court hears arguments in abortion pill case – CBS News


    Watch CBS News



    The Supreme Court on Tuesday heard arguments in a case that could upend access to a widely used abortion medication. Jan Crawford reports.

    Be the first to know

    Get browser notifications for breaking news, live events, and exclusive reporting.


    [ad_2]

    Source link

  • Tech companies designing health care devices specifically for women

    Tech companies designing health care devices specifically for women

    [ad_1]

    Tech companies designing health care devices specifically for women – CBS News


    Watch CBS News



    Women tech entrepreneurs are taking it upon themselves to help close the gender health care gap by designing medical devices specifically for women. Meg Oliver takes a look at some of the innovations.

    Be the first to know

    Get browser notifications for breaking news, live events, and exclusive reporting.


    [ad_2]

    Source link

  • Roche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage Study

    Roche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage Study

    [ad_1]

    By Mauro Orru

    Roche Holding said its investigational treatment, inavolisib, showed promise in a late-stage study to treat patients with breast cancer.

    The Swiss pharmaceutical company said Tuesday that the phase 3 study met its primary endpoint of progression-free survival, showing that inavolisib, in combination with palbociclib and fulvestrant, delivered a statistically significant and clinically meaningful improvement compared to palbociclib and fulvestrant alone.

    While Roche acknowledged that overall survival data were immature at this stage, it said it had observed a clear positive trend. The inavolisib combination was well tolerated.

    The group said inavolisib is an investigational, oral targeted treatment with potential to provide durable disease control.

    Write to Mauro Orru at mauro.orru@wsj.com

    

    

    [ad_2]
    

    Source link 
    

    
			
    
		
    
		
	
  • 
		
		
    
			
    How do abortion rights impact voter turnout?
    
			
    How do abortion rights impact voter turnout?
    
			
     [ad_1]
    

    How do abortion rights impact voter turnout? – CBS News
    



    
    
    

    Watch CBS News
    

        
    
  

    

    


    
      

    

                    Ohio voters on Tuesday rejected a proposal that would’ve made it more difficult to change the state’s constitution. Abortion rights supporters are celebrating the outcome of the vote because of a November ballot question on enshrining reproductive rights in the Ohio constitution. CBS News political director Fin Gómez shares takeaways from the result.
                      
    

    

    
    

        
    

    

    
  
    

    Be the first to know
    

    Get browser notifications for breaking news, live events, and exclusive reporting.
    

      
    
  

    

    

    [ad_2]
    

    Source link 
    

    
			
    
		
    
		
	
  • 
		
		
    
			
    FDA pulls preterm-birth drug Makena and its generics from market after 12 years
    
			
    FDA pulls preterm-birth drug Makena and its generics from market after 12 years
    
			
     [ad_1]
    

    

    

    The U.S. Food and Drug Administration said Thursday it had reached a final decision to fully withdraw approval of preterm-birth drug Makena and its generics, a full 12 years after the treatment hit the market.
    

    The drug was approved in 2011 using the agency’s accelerated-approval pathway as a treatment to reduce the risk of spontaneous preterm birth in pregnant women who had a history of the condition. 
    

    The…
    
    

    

    

    [ad_2]
    

    Source link